Sage Therapeutics, Inc. Earnings Per Share, Basic in USD/shares from 2018 to Q2 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Sage Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2018 to Q2 2025.
  • Sage Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2025 was -0.79 USD/shares, a 53.5% increase year-over-year.
  • Sage Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2025 was -4 USD/shares, a 34% increase year-over-year.
  • Sage Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -6.59 USD/shares, a 27.2% increase from 2023.
  • Sage Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -9.05 USD/shares, a 0.78% decline from 2022.
  • Sage Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -8.98 USD/shares, a 15.1% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

Sage Therapeutics, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$4 -$1 +$0.91 +53.5% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-30
Q1 2025 -$5 -$1 +$0.79 +43.9% Jan 1, 2025 Mar 31, 2025 10-Q 2025-04-29
Q4 2024 -$6 -$2 -$1 -189% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-11
Q3 2024 -$5 -$2 +$1.84 +54.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-29
Q2 2024 -$7 -$2 +$0.98 +36.6% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-30
Q1 2024 -$8 -$2 +$0.66 +26.8% Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-29
Q4 2023 -$9 -$1 +$1.93 +78.1% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-11
Q3 2023 -$10 -$3 -$1 -45.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 -$9 -$3 -$1 -25.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 -$9 -$2 $0 -18.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 -$8 -$2 Oct 1, 2022 Dec 31, 2022 10-K 2025-02-11
Q3 2022 -$2 $0 -4.53% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$2 $0 -16.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$2 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q3 2021 -$2 $0 -8.87% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$2 +$0.80 +30.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q4 2020 $11.00 $18.70 Oct 1, 2020 Dec 31, 2020 10-K 2021-02-24
Q3 2020 -$2 Jul 1, 2020 Sep 30, 2020 10-K 2021-02-24
Q2 2020 -$3 Apr 1, 2020 Jun 30, 2020 10-K 2021-02-24
Q1 2020 -$2 Jan 1, 2020 Mar 31, 2020 10-K 2021-02-24

Sage Therapeutics, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$7 +$2.46 +27.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-11
2023 -$9 $0 -0.78% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-11
2022 -$9 -$1 -15.1% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-11
2021 -$8 -$20 -167% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-14
2020 $11.70 +$25.00 Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 -$13 -$5 -65.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$8 Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.